300347 Stock Overview
Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 300347 from our risk checks.
Hangzhou Tigermed Consulting Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥57.70 |
| 52 Week High | CN¥94.20 |
| 52 Week Low | CN¥36.12 |
| Beta | 0.71 |
| 1 Month Change | 13.34% |
| 3 Month Change | 31.41% |
| 1 Year Change | -36.57% |
| 3 Year Change | -63.13% |
| 5 Year Change | 30.35% |
| Change since IPO | 1,284.80% |
Recent News & Updates
Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Apr 08
Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues
Apr 04Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models
Apr 01Recent updates
Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Apr 08Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues
Apr 04Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models
Apr 01Shareholder Returns
| 300347 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 16.2% | -1.5% | -0.3% |
| 1Y | -36.6% | -39.0% | -14.6% |
Return vs Industry: 300347 exceeded the CN Life Sciences industry which returned -39% over the past year.
Return vs Market: 300347 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 300347 volatility | |
|---|---|
| 300347 Average Weekly Movement | 9.4% |
| Life Sciences Industry Average Movement | 9.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300347's share price has been volatile over the past 3 months.
Volatility Over Time: 300347's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 9,701 | Xiaochun Cao | www.tigermedgrp.com |
Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services.
Hangzhou Tigermed Consulting Co., Ltd Fundamentals Summary
| 300347 fundamental statistics | |
|---|---|
| Market cap | CN¥42.86b |
| Earnings (TTM) | CN¥1.69b |
| Revenue (TTM) | CN¥7.24b |
29.5x
P/E Ratio6.9x
P/S RatioIs 300347 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300347 income statement (TTM) | |
|---|---|
| Revenue | CN¥7.24b |
| Cost of Revenue | CN¥4.48b |
| Gross Profit | CN¥2.76b |
| Other Expenses | CN¥1.07b |
| Earnings | CN¥1.69b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.96 |
| Gross Margin | 38.10% |
| Net Profit Margin | 23.36% |
| Debt/Equity Ratio | 11.1% |
How did 300347 perform over the long term?
See historical performance and comparison